×

GSK Will Defend Tier Pricing: CEO

7:40 PM ET Thu, 18 Oct 2012

Andrew Witty, Global CEO, GlaxosmithKline speaks to CNBC TV-18's Shereen Bhan on the current patent price debate in the drug industry. He states GSK will continue striving to defend tier pricing.